DOI: 10.1055/s-00043364

Pharmaceutical Fronts

References

Goldner T, Hewlett G, Ettischer N, Ruebsamen-Schaeff H, Zimmermann H, Lischka P.
The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase.

J Virol 2011;
85 (20) 10884-10893

Download Bibliographical Data

Access:
Access: